Clinical Trial Update: Development of Patient Derived Xenografts (PDXs) and Analysis of Tyrosine Kinase Receptor Expression in Patients With Squamous Cell Head and Neck Cancer (HNSCC) to Study Resistance Mechanisms Induced by Standard Therapy

View source ↗

Summary

This clinical trial update describes developing patient-derived xenografts from head and neck squamous cell carcinoma patients and analyzing tyrosine kinase rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Squamous Cell Tumors of the Head and Neck (HNSCC) | Status: NOT_YET_RECRUITING